Literature DB >> 7851542

A case of squamous cell carcinoma complicating hidradenitis suppurativa.

V K Shukla1, L E Hughes.   

Abstract

A case of extensive squamous cell carcinoma arising in widespread perianal and inguinal hidradenitis suppurativa is used to illustrate the pathological features which influence management. The surgical pathology, with wide extension along subcutaneous sinuses, frequently leads to the view that it is incurable. A planned surgical approach, using both immediate frozen section and delayed paraffin histology to assess clearance margins allowed complete surgical excision in two stages. Colostomy is not a necessary part of management and healing by granulation is an acceptable alternative to extensive reconstruction procedures. Radiotherapy and chemotherapy, sometimes used in palliation mode, are not likely to be beneficial.

Entities:  

Mesh:

Year:  1995        PMID: 7851542     DOI: 10.1016/s0748-7983(05)80084-8

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

Review 1.  Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa.

Authors:  Gael M Maclean; David J Coleman
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

2.  The perils of a defective medical communication: fatal neglected squamous cell carcinoma arising in perineal hidradenitis suppurativa.

Authors:  Calogero Pagliarello; Andrea Paradisi
Journal:  Case Rep Dermatol       Date:  2011-01-07

Review 3.  Recent developments in the surgical management of perianal fistula for Crohn's disease.

Authors:  Cristina B Geltzeiler; Nicole Wieghard; Vassiliki L Tsikitis
Journal:  Ann Gastroenterol       Date:  2014

Review 4.  Successful surgical treatment for squamous cell carcinoma arising from hidradenitis suppurativa: A case report and literature review.

Authors:  Cheng Huang; Zhichao Lai; Mu He; Biyun Zhai; Liangrui Zhou; Xiao Long
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.